Reuters - Video

Edition: US | UK | IN | CN | JP

video Finance Videos

Pfizer's, Merck's revenue disappoint investors

Tuesday, May 01, 2018 - 01:05

Sales of Pfizer's blockbuster drug Ibrance zoomed higher but missed forecasts. Sales of Merck's cancer drug Keytruda catapulted higher, but overall revenue disappointed Wall Street. Fred Katayama reports.

▲ Hide Transcript

View Transcript

Sales of Pfizer's blockbuster drug Ibrance zoomed higher but missed forecasts. Sales of Merck's cancer drug Keytruda catapulted higher, but overall revenue disappointed Wall Street. Fred Katayama reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Pfizer's, Merck's revenue disappoint investors

Tuesday, May 01, 2018 - 01:05